IndraLab

Statements


PR-619 inhibits USP4. 1 / 1
| 1

reach
"Finally, PR-619, which has been proven to inhibit the activities of USP4 and other deubiquitinases, could inhibit cell viability and NF-κB signaling in gastric cancer cells."